Vinaya Soundararajan1, Jennifer Lor1,2, Anna B Fishbein2. 1. University of Illinois at Chicago, Department of Internal Medicine, Chicago, IL USA. 2. Ann & Robert H. Lurie Children's Hospital Department of Allergy, Division of Pediatric Allergy & Immunology, Chicago IL, USA.
Abstract
PURPOSE OF THE REVIEW: Skin disease is associated with obstructive sleep apnea (OSA) both epidemiologically and mechanistically. In this review we highlight conditions which have a well-established link to obstructive sleep apnea, such as psoriasis and atopic dermatitis. RECENT FINDINGS: We describe putative mechanistic links between OSA and skin disease involving inflammatory pathways, obesity, mechanical upper airways obstruction, and hypoxia. In the context of these mechanisms we describe specific skin conditions, and other conditions which are associated with both skin manifestations (including hair/nail findings) and OSA. The risks/ benefits of CPAP in the context of skin disease are also reviewed. SUMMARY: We conclude that further research is needed to understand the mechanisms behind the associations between OSA and skin disease. Given the frequent co-occurrence of OSA and skin conditions, there would be great benefit for OSA clinical trials to consider improvement in skin disease as an outcome measure.
PURPOSE OF THE REVIEW: Skin disease is associated with obstructive sleep apnea (OSA) both epidemiologically and mechanistically. In this review we highlight conditions which have a well-established link to obstructive sleep apnea, such as psoriasis and atopic dermatitis. RECENT FINDINGS: We describe putative mechanistic links between OSA and skin disease involving inflammatory pathways, obesity, mechanical upper airways obstruction, and hypoxia. In the context of these mechanisms we describe specific skin conditions, and other conditions which are associated with both skin manifestations (including hair/nail findings) and OSA. The risks/ benefits of CPAP in the context of skin disease are also reviewed. SUMMARY: We conclude that further research is needed to understand the mechanisms behind the associations between OSA and skin disease. Given the frequent co-occurrence of OSA and skin conditions, there would be great benefit for OSA clinical trials to consider improvement in skin disease as an outcome measure.
Authors: Abd A Tahrani; Asad Ali; Neil T Raymond; Safia Begum; Kiran Dubb; Shanaz Mughal; Biju Jose; Milan K Piya; Anthony H Barnett; Martin J Stevens Journal: Am J Respir Crit Care Med Date: 2012-06-21 Impact factor: 21.405
Authors: Anna B Fishbein; Kelly Mueller; Lacey Kruse; Peter Boor; Stephen Sheldon; Phyllis Zee; Amy S Paller Journal: J Am Acad Dermatol Date: 2017-10-28 Impact factor: 11.527
Authors: Fernando Santamaria-Martos; Ivan Benítez; Cristina Girón; Ferran Barbé; Miguel-Angel Martínez-García; Luis Hernández; Josep M Montserrat; Eduardo Nagore; Antonio Martorell; Francisco Campos-Rodriguez; Jaime Corral; Valentin Cabriada; Jorge Abad; Olga Mediano; Maria F Troncoso; Irene Cano-Pumarega; Ana Maria Fortuna Gutierrez; Trinidad Diaz-Cambriles; Maria Somoza-Gonzalez; Isaac Almendros; Ramon Farre; David Gozal; Manuel Sánchez-de-la-Torre Journal: Eur Respir J Date: 2018-03-15 Impact factor: 16.671
Authors: Anna B Fishbein; Olivia Vitaterna; Isabel M Haugh; Aakash A Bavishi; Phyllis C Zee; Fred W Turek; Stephen H Sheldon; Jonathan I Silverberg; Amy S Paller Journal: J Allergy Clin Immunol Date: 2015-11 Impact factor: 10.793
Authors: Anna B Fishbein; Brian T Cheng; Caroline C Tilley; Wendy Smith Begolka; Adam C Carle; Christopher B Forrest; Phillis C Zee; Amy S Paller; James W Griffith Journal: J Allergy Clin Immunol Pract Date: 2021-05-12